A Scharfman
Impact in
-
- Cystic Fibrosis Research Advances
- Neonatal Respiratory Health Research
- Occupational and environmental lung diseases
- Inhalation and Respiratory Drug Delivery
Papers in
-
- Glycosylation and Glycoproteins Research 6
- Protein Hydrolysis and Bioactive Peptides 2
-
- Cystic Fibrosis Research Advances 5
- Occupational and environmental lung diseases 4
- Co-authors
- G Lamblin (10 shared papers)Pascal Roussel (7 shared papers)Nicole Houdret (6 shared papers)P Roussel (4 shared papers)Reuben Ramphal (3 shared papers)Christophe Carnoy (3 shared papers)Patrick O. Humbert (2 shared papers)Jean‐Marie Beau (1 shared paper)
In The Last Decade
A Scharfman
25 papers receiving 402 citations
Peers
Comparison fields: 5 of 80
- Pulmonary and Respiratory Medicine 163
- Endocrinology 25
- Microbiology 28
- Molecular Biology 209
- Cell Biology 43
Countries citing papers authored by A Scharfman
This map shows the geographic impact of A Scharfman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Scharfman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Scharfman more than expected).
Fields of papers citing papers by A Scharfman
This network shows the impact of papers produced by A Scharfman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Scharfman. The network helps show where A Scharfman may publish in the future.
Co-authors
The 25 scholars most cited alongside A Scharfman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 66 | |
| 2 | 1999 | 58 | |
| 3 | 1986 | 46 | |
| 4 | 1996 | 38 | |
| 5 | 1996 | 33 | |
| 6 | 1991 | 22 | |
| 7 | 1995 | 21 | |
| 8 | 1976 | 19 | |
| 9 | 1983 | 18 | |
| 10 | Selective inhibition of normal murine myelopoiesis "in vitro" by a Hox 2.3 antisense oligodeoxynucleotide. | 1992 | 16 |
| 11 | 1972 | 15 | |
| 12 | 1983 | 15 | |
| 13 | 1981 | 10 | |
| 14 | 1989 | 9 | |
| 15 | 1979 | 8 | |
| 16 | Recombinant human granulocyte macrophage colony-stimulating factor (rhGM-CSF) induces human macrophage production of transforming growth factor-alpha. | 1991 | 6 |
| 17 | 1975 | 5 | |
| 18 | 1991 | 5 | |
| 19 | [Serum alpha macroglobulins of the rabbit]. | 1973 | 3 |
| 20 | 1976 | 2 |
About A Scharfman
A Scharfman is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Genetics, Endocrinology and Plant Science, having authored 26 papers that have together received 424 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (6 papers), Cystic Fibrosis Research Advances (5 papers), Occupational and environmental lung diseases (4 papers), Diabetes and associated disorders (3 papers), Bacterial Genetics and Biotechnology (3 papers), Protein Hydrolysis and Bioactive Peptides (2 papers), Infant Nutrition and Health (2 papers) and Carbohydrate Chemistry and Synthesis (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (163 citations), Endocrinology (25 citations), Microbiology (28 citations), Molecular Biology (209 citations) and Cell Biology (43 citations). A Scharfman has collaborated with scholars based in France, China and Tunisia. Frequent co-authors include G Lamblin, Pascal Roussel, Nicole Houdret, P Roussel, Reuben Ramphal, Christophe Carnoy, Patrick O. Humbert, Jean‐Marie Beau, Joël Mazurier and Philippe Roussel. Their work appears in journals such as Infection and Immunity, Clinica Chimica Acta, European Respiratory Journal, Lung and Biochimica et Biophysica Acta (BBA) - General Subjects.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.